Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to N-Terminal Pro-B-Type Natriuretic Peptide: Insights From the DAPA-HF Trial.
Jawad Haider ButtCarly AdamsonKieran F DochertyRudolf A de BoerMark Colquhoun PetrieCatherine M ViscoliMikhail N KosiborodAnna Maria LangkildeDaniel LindholmFelipe A MartinezOlof F BengtssonMorten SchouEileen O'MearaPiotr PonikowskiMarc S SabatineMikaela SjöstrandScott D SolomonPardeep S JhundJohn J V McMurrayLars KøberPublished in: Circulation. Heart failure (2021)
URL: https://www.clinicaltrials.gov; Unique identifier: NCT03036124.